{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T19:07:38Z","timestamp":1782932858774,"version":"3.54.5"},"reference-count":39,"publisher":"Scientific Scholar","issue":"04","license":[{"start":{"date-parts":[[2024,4,26]],"date-time":"2024-04-26T00:00:00Z","timestamp":1714089600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["South Asian J Cancer"],"published-print":{"date-parts":[[2025,10]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Tuberculosis (TB) remains an important public health problem worldwide. Risk of acquiring TB in patients diagnosed with cancers remains high and can result due to reactivation or reinfection. We share the experience in a large tertiary care hospital.<\/jats:p>\n                  <jats:p>Clinical samples from presumptive TB patients while on cancer therapy were tested by smear Ziehl\u2013Neelsen (ZN) staining, GeneXpert MTB\/RIF (Gx), TB polymerase chain reaction (PCR), and liquid culture (MGIT 960) from January 1, 2019, to December 31, 2022.<\/jats:p>\n                  <jats:p>Stata 14.0 software was used for statistical analysis. The p-value calculation was done by Pearson's chi-square test.<\/jats:p>\n                  <jats:p>Of 906 patients investigated, 42 (4.64%) tested positive for TB. Seven (1.37%) tested positive by ZN staining, 10 patients (6%) had culture positive by MGIT, 20 (10.53%) and 5 (13.51%) samples were positive by Gx and PCR, respectively. Maximum number of TB-positive patients were found to be suffering from carcinoma lung (28%) followed by leukemia (25%), gastrointestinal cancer (13%), and genitourinary cancer (13%), respectively. Seven of the 42 patients succumbed to the disease; the cases belonged to Hodgkin's lymphoma (75% mortality), leukemia (30% mortality), and genitourinary cancer (20% mortality).<\/jats:p>\n                  <jats:p>The incidence of active TB is high in cancer patients, especially lung cancer, leukemia, gastrointestinal, and genitourinary cancers. Mortality was high in Hodgkin's lymphoma patients who developed TB. Screening for TB at the time of diagnosis of a high TB risk cancer would help initiate early treatment. We recommend targeted screening for TB in patients with these high-risk cancers, at the time of diagnosis and periodically through cancer treatment.<\/jats:p>","DOI":"10.1055\/s-0044-1786363","type":"journal-article","created":{"date-parts":[[2024,4,26]],"date-time":"2024-04-26T18:48:17Z","timestamp":1714157297000},"page":"771-776","source":"Crossref","is-referenced-by-count":2,"title":["Active Tuberculosis Risk Associated with Malignancies: A 4-Year Retrospective Study in a Tertiary Care Hospital"],"prefix":"10.25259","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9139-134X","authenticated-orcid":false,"given":"Priyamvada","family":"Roy","sequence":"additional","affiliation":[{"name":"Department of Microbiology, All India Institute of Medical Sciences, New Delhi, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kiran","family":"Bala","sequence":"additional","affiliation":[{"name":"Department of Microbiology, All India Institute of Medical Sciences, New Delhi, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaya","family":"Biswas","sequence":"additional","affiliation":[{"name":"Department of Microbiology, All India Institute of Medical Sciences, New Delhi, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Javed","family":"Ahmed","sequence":"additional","affiliation":[{"name":"Department of Microbiology, All India Institute of Medical Sciences, New Delhi, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raunak","family":"Bir","sequence":"additional","affiliation":[{"name":"Department of Microbiology, All India Institute of Medical Sciences, New Delhi, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vishwanath","family":"Yadav","sequence":"additional","affiliation":[{"name":"Department of Microbiology, All India Institute of Medical Sciences, New Delhi, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashit","family":"Xess","sequence":"additional","affiliation":[{"name":"Department of Microbiology, All India Institute of Medical Sciences, New Delhi, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanjana","family":"Kumari","sequence":"additional","affiliation":[{"name":"Department of Microbiology, All India Institute of Medical Sciences, New Delhi, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Prabhat Singh","family":"Malik","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, All India Institute of Medical Sciences, New Delhi, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S. V. S.","family":"Deo","sequence":"additional","affiliation":[{"name":"Department of Surgical Oncology, All India Institute of Medical Sciences, New Delhi, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atul","family":"Batra","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, All India Institute of Medical Sciences, New Delhi, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atul","family":"Sharma","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, All India Institute of Medical Sciences, New Delhi, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8753-9743","authenticated-orcid":false,"given":"Urvashi B.","family":"Singh","sequence":"additional","affiliation":[{"name":"Department of Microbiology, All India Institute of Medical Sciences, New Delhi, India"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10894","published-online":{"date-parts":[[2024,4,26]]},"reference":[{"issue":"09","key":"ref1","doi-asserted-by":"crossref","first-page":"4950","DOI":"10.21037\/jtd.2020.02.50","article-title":"Active tuberculosis risk associated with malignancies: an 18-year retrospective cohort study in Korea","volume":"12","author":"J Cheon","year":"2020","journal-title":"J Thorac Dis"},{"key":"ref2","first-page":"1","article-title":"Controlling tuberculosis in the United States: recommendations from the American thoracic society, CDC, and the Infectious Diseases Society of America","volume":"54","author":"Z Taylor","year":"2005","journal-title":"MMWR Recomm Rep"},{"issue":"12","key":"ref3","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1001\/jama.1986.03370120057023","article-title":"Preventive therapy with isoniazid. Cost-effectiveness of different durations of therapy","volume":"255","author":"D E Snider Jr","year":"1986","journal-title":"JAMA"},{"issue":"05","key":"ref4","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1164\/ajrccm\/140.5.1189","article-title":"Experimental short-course preventive therapy of tuberculosis with rifampin and pyrazinamide","volume":"140","author":"H F Lecoeur","year":"1989","journal-title":"Am Rev Respir Dis"},{"key":"ref6","volume-title":"Canadian Tuberculosis Standards","year":"2014","edition":"7th ed"},{"key":"ref7","volume-title":"Guidelines on the Management of Latent Tuberculosis Infection","year":"2015"},{"key":"ref8","volume-title":"Korean Guidelines for Tuberculosis. Joint Committee for the Revision of Korean Guidelines for Tuberculosis. 3rd ed","year":"2017"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1146\/annurev-immunol-032712-095939","article-title":"The immune response in tuberculosis","volume":"31","author":"A O'Garra","year":"2013","journal-title":"Annu Rev Immunol"},{"issue":"03","key":"ref10","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1111\/j.1440-1843.2008.01282.x","article-title":"Solid-organ malignancy as a risk factor for tuberculosis","volume":"13","author":"H R Kim","year":"2008","journal-title":"Respirology"},{"issue":"02","key":"ref11","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1017\/S0950268897007917","article-title":"The natural history of tuberculosis: the implications of age-dependent risks of disease and the role of reinfection","volume":"119","author":"E Vynnycky","year":"1997","journal-title":"Epidemiol Infect"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"62","DOI":"10.14745\/ccdr.v43i34a01","article-title":"Latent tuberculosis infection: an overview","volume":"43","author":"S Kiazyk","year":"2017","journal-title":"Can Commun Dis Rep"},{"issue":"02","key":"ref13","doi-asserted-by":"crossref","first-page":"1700157","DOI":"10.1183\/13993003.00157-2017","article-title":"Risk of tuberculosis in patients with solid cancers and haematological malignancies: a systematic review and meta-analysis","volume":"50","author":"C C Dobler","year":"2017","journal-title":"Eur Respir J"},{"issue":"08","key":"ref14","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1111\/j.1469-0691.2004.00954.x","article-title":"Mycobacterium tuberculosis at a comprehensive cancer centre: active disease in patients with underlying malignancy during 1990-2000","volume":"10","author":"G R De La Rosa","year":"2004","journal-title":"Clin Microbiol Infect"},{"issue":"11","key":"ref15","doi-asserted-by":"crossref","first-page":"1592","DOI":"10.1086\/503917","article-title":"The risk of tuberculosis in patients with cancer","volume":"42","author":"M Kamboj","year":"2006","journal-title":"Clin Infect Dis"},{"key":"ref16","volume-title":"Latent Tuberculosis Infection: Updated and Consolidated Guidelines for Programmatic Management","year":"2018"},{"issue":"06","key":"ref17","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.1183\/13993003.01245-2015","article-title":"Management of latent Mycobacterium tuberculosis infection: WHO guidelines for low tuberculosis burden countries","volume":"46","author":"H Getahun","year":"2015","journal-title":"Eur Respir J"},{"issue":"05","key":"ref18","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1093\/cid\/ciw838","article-title":"Risk of active tuberculosis in patients with cancer: a systematic review and meta-analysis","volume":"64","author":"M P Cheng","year":"2017","journal-title":"Clin Infect Dis"},{"issue":"02","key":"ref19","doi-asserted-by":"crossref","first-page":"100643","DOI":"10.1016\/j.currproblcancer.2020.100643","article-title":"Impact of active tuberculosis on treatment decisions in cancer","volume":"45","author":"C K Nair","year":"2021","journal-title":"Curr Probl Cancer"},{"issue":"09","key":"ref20","doi-asserted-by":"crossref","first-page":"2715","DOI":"10.31557\/APJCP.2020.21.9.2715","article-title":"Incidence of and risk factors for tuberculosis among cancer patients in endemic area: a regional cohort study","volume":"21","author":"S Nanthanangkul","year":"2020","journal-title":"Asian Pac J Cancer Prev"},{"issue":"01","key":"ref21","doi-asserted-by":"crossref","first-page":"11901","DOI":"10.1038\/s41598-019-48395-8","article-title":"The burdens of tuberculosis on patients with malignancy: incidence, mortality and relapse","volume":"9","author":"C C Shu","year":"2019","journal-title":"Sci Rep"},{"key":"ref22","volume-title":"Public Health Mycobacteriology: A Guide for the Level III Laboratory","author":"P T Kent","year":"1985"},{"issue":"01","key":"ref24","first-page":"125","article-title":"Aerodigestive tract, lung and haematological cancers are risk factors for tuberculosis: an 8-year population-based study","volume":"15","author":"C Y Wu","year":"2011","journal-title":"Int J Tuberc Lung Dis"},{"key":"ref25","volume-title":"Recherches sur la phthisie pulmonaire: Ouvrage lu \u00e0 la Soci\u00e9t\u00e9 de la facult\u00e9 de m\u00e9decine de Paris, dans diverses s\u00e9ances, en 1809 et","author":"G L Bayle","year":"1810"},{"issue":"03","key":"ref26","first-page":"335","article-title":"A common medical error: lung cancer misdiagnosed as sputum negative tuberculosis","volume":"10","author":"V K Singh","year":"2009","journal-title":"Asian Pac J Cancer Prev"},{"issue":"04","key":"ref27","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1111\/crj.12094","article-title":"Epidemiology of active tuberculosis in lung cancer patients: a systematic review","volume":"8","author":"A Christopoulos","year":"2014","journal-title":"Clin Respir J"},{"issue":"12","key":"ref28","doi-asserted-by":"crossref","first-page":"2936","DOI":"10.1002\/ijc.24636","article-title":"Facts and fiction of the relationship between preexisting tuberculosis and lung cancer risk: a systematic review","volume":"125","author":"H Y Liang","year":"2009","journal-title":"Int J Cancer"},{"issue":"01","key":"ref29","first-page":"15","article-title":"Mechanisms of immune response regulation in lung cancer","volume":"3","author":"J Domagala-Kulawik","year":"2014","journal-title":"Transl Lung Cancer Res"},{"issue":"01","key":"ref30","doi-asserted-by":"crossref","first-page":"e2014026","DOI":"10.4084\/mjhid.2014.026","article-title":"Tuberculosis in patients with haematological malignancies","volume":"6","author":"L Anibarro","year":"2014","journal-title":"Mediterr J Hematol Infect Dis"},{"key":"ref31","first-page":"28","article-title":"[Mechanisms of immunosuppression in leukemia]","volume":"59","author":"W Luczy\u0144ski","year":"2005","journal-title":"Postepy Hig Med Dosw"},{"issue":"47","key":"ref32","doi-asserted-by":"crossref","first-page":"e2163","DOI":"10.1097\/MD.0000000000002163","article-title":"Incidence of and risk factors for tuberculosis (TB) in gastric cancer patients in an area endemic for TB: a nationwide population-based matched cohort study","volume":"94","author":"W L Fang","year":"2015","journal-title":"Medicine (Baltimore)"},{"issue":"04","key":"ref33","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1620\/tjem.240.281","article-title":"Treatment outcomes of patients treated for pulmonary tuberculosis after undergoing gastrectomy","volume":"240","author":"I Y Jung","year":"2016","journal-title":"Tohoku J Exp Med"},{"issue":"01","key":"ref34","doi-asserted-by":"crossref","first-page":"216","DOI":"10.4251\/wjgo.v14.i1.216","article-title":"Immune evasion mechanisms and therapeutic strategies in gastric cancer","volume":"14","author":"E S Ma","year":"2022","journal-title":"World J Gastrointest Oncol"},{"issue":"01","key":"ref35","doi-asserted-by":"crossref","first-page":"59","DOI":"10.4103\/0970-2113.125985","article-title":"A case of concomitant Hodgkin's lymphoma with tuberculosis","volume":"31","author":"R C Reddy","year":"2014","journal-title":"Lung India"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1182\/asheducation-2005.1.231","article-title":"Immunobiology and pathophysiology of Hodgkin lymphomas","volume":"\u2022\u2022\u2022","author":"S Poppema","year":"2005","journal-title":"Hematology (Am Soc Hematol Educ Program)"},{"issue":"01","key":"ref37","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1038\/sj.thj.6200219","article-title":"Pulmonary tuberculosis in children with Hodgkin's lymphoma","volume":"4","author":"Z Karakas","year":"2003","journal-title":"Hematol J"},{"issue":"03","key":"ref38","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1080\/10428194.2018.1499904","article-title":"The risk of tuberculosis in cancer patients is greatest in lymphoma and myelodysplastic syndrome\/myeloproliferative neoplasm: a large population-based cohort study","volume":"60","author":"C Ganzel","year":"2019","journal-title":"Leuk Lymphoma"},{"issue":"03","key":"ref39","first-page":"ACRT-169","article-title":"A combination of hodgkin's lymphoma and tuberculosis occurred with bilateral malignant pleural effusions","volume":"2018","author":"D Valchev","year":"2018","journal-title":"Ann Case Rep"},{"issue":"01","key":"ref40","doi-asserted-by":"crossref","first-page":"35","DOI":"10.5045\/br.2013.48.1.35","article-title":"Poor prognostic significance of Mycobacterium tuberculosis infection during bortezomib-containing chemotherapy in patients with multiple myeloma","volume":"48","author":"J S Ahn","year":"2013","journal-title":"Blood Res"},{"issue":"01","key":"ref41","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1186\/s40425-019-0717-7","article-title":"Reactivation of tuberculosis in cancer patients following administration of immune checkpoint inhibitors: current evidence and clinical practice recommendations","volume":"7","author":"A Anastasopoulou","year":"2019","journal-title":"J Immunother Cancer"}],"container-title":["South Asian Journal of Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.thieme-connect.de\/products\/ejournals\/pdf\/10.1055\/s-0044-1786363.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,11]],"date-time":"2026-06-11T11:13:19Z","timestamp":1781176399000},"score":1,"resource":{"primary":{"URL":"https:\/\/journal.sajc.org\/active-tuberculosis-risk-associated-with-malignancies-a-4-year-retrospective-study-in-a-tertiary-care-hospital\/"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4,26]]},"references-count":39,"journal-issue":{"issue":"04","published-online":{"date-parts":[[2025,12,29]]},"published-print":{"date-parts":[[2025,10]]}},"URL":"https:\/\/doi.org\/10.1055\/s-0044-1786363","archive":["Portico","CLOCKSS"],"relation":{},"ISSN":["2278-330X","2278-4306"],"issn-type":[{"value":"2278-330X","type":"print"},{"value":"2278-4306","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,4,26]]}}}